Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer

NCT02107287 is registered in ClinicalTrials.gov with Sergio Faria as lead sponsor.

NCT NCT02107287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02107287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer
Lead sponsor
Sergio Faria
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2011
Completion date
June 30, 2016
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high risk prostate cancer